Fennec Pharmaceuticals Resubmits New Drug Application To U.S. Food And Drug Administration For Pedmark Research Triangle Park, NC, May 28, 2021 – Fennec Pharmaceuticals Inc.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
